Maryam Koopaie

Prof. Maryam Koopaie

Tehran University of Medical Sciences, Tehran, Tehrān, Iran
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 March 2022 in Cancer Medicine
Verified
Journal Article
Open access
MKMaryam Koopaie
Maryam Koopaie
SKSajad Kolahdooz
Sajad Kolahdooz
MFMahnaz Fatahzadeh
Mahnaz Fatahzadeh
SMSoheila Manifar
Soheila Manifar
Background: Salivary diagnostics and their utility as a nonaggressive approach for breast cancer diagnosis have been extensively studied in recent years. This meta‐analysis assesses the diagnostic value of salivary biomarkers in differentiating between patients with breast cancer and controls.Methods: We conducted a meta‐analysis and systematic review of studies related to salivary diagnostics published in PubMed, EMBASE, Scopus, Ovid, Science Direct, Web of Science (WOS), and Google Scholar. The articles were chosen utilizing inclusion and exclusion criteria, as well as assessing their quality. Specificity and sensitivity, along with negative and positive likelihood ratios (NLR and PLR) and diagnostic odds ratio (DOR), were calculated based on random‐ or fixed‐effects model. Area under the curve (AUC) and summary receiver‐operating characteristic (SROC) were plotted and evaluated, and Fagan's Nomogram was evaluated for clinical utility.Results: Our systematic review and meta‐analysis included 14 papers containing 121 study units with 8639 adult subjects (4149 breast cancer patients and 4490 controls without cancer). The pooled specificity and sensitivity were 0.727 (95% CI: 0.713–0.740) and 0.717 (95% CI: 0.703–0.730), respectively. The pooled NLR and PLR were 0.396 (95% CI: 0.364–0.432) and 2.597 (95% CI: 2.389–2.824), respectively. The pooled DOR was 7.837 (95% CI: 6.624–9.277), with the AUC equal to 0.801. The Fagan's nomogram showed post‐test probabilities of 28% and 72% for negative and positive outcomes, respectively. We also conducted subgroup analyses to determine specificity, sensitivity, DOR, PLR, and NLR based on the mean age of patients (≤52 or >52 years old), saliva type (stimulated and unstimulated saliva), biomarker measurement method (mass spectrometry [MS] and non‐MS measurement methods), sample size (≤55 or >55), biomarker type (proteomics, metabolomics, transcriptomics and proteomics, and reagent‐free biophotonic), and nations.Conclusion: Saliva, as a noninvasive biomarker, has the potential to accurately differentiate breast cancer patients from healthy controls.

1 July 2019 in British Journal of Oral and Maxillofacial Surgery
Verified
Journal Article
Closed access
MKMaryam Koopaie
Maryam Koopaie
SKS. Kolahdouz
S. Kolahdouz
EKE.M. Kolahdouz
E.M. Kolahdouz

15 March 2019 in Dental and Medical Problems
Verified
Journal Article
Open access
MKMaryam Koopaie
Maryam Koopaie
MFMahnaz Fatahzadeh
Mahnaz Fatahzadeh
SJSana Jahangir
Sana Jahangir
RBRonak Bakhtiari
Ronak Bakhtiari
Dental caries is considered the most common infectious disease in humans worldwide. Cariogenesis is the outcome of a complex interaction between the host's oral flora and diet. The consumption of snacks such as cake, which have the potential to promote dental caries, has increased. The aim of this study was to investigate the effect of including probiotic bacteria (Bacillus coagulans - B. coagulans) in consumed snack cake on the Streptococcus mutans (S. mutans) count and salivary pH. We conducted a randomized, double-blind, cross-sectional cohort study on 40 healthy volunteers. The subjects were divided into 2 groups. In the 1st group, the subjects consumed probiotic cake as breakfast for 1 week and then, following a 4-week wash-out period, consumed regular cake as breakfast for 1 week. In the other group, the administration of probiotic and regular cake was reversed. For both groups, samples of at least 5 mL of non-stimulated saliva were collected using the spitting technique before and after the 1st and the 6th week. A colony counter was used to determine the number of S. mutans colonies. Salivary pH was measured before eating (8-9 a.m.). We detected no statistically significant difference in the S. mutans count before and after the consumption of probiotic cake, but noted a statistically significant difference in the count before and after the consumption of regular cake. We did not detect a significant difference in salivary pH with respect to the consumption of probiotic and regular cake, although the consumption of both foods caused a drop in salivary pH. The addition of probiotic bacteria to sweet snack cake caused a minimal increase in the salivary count of S. mutans, a bacterial species with a definite role in cariogenesis, but did not impact salivary pH. Since probiotic cake has a slight impact on the S. mutans count, it is preferred over regular cake as a snack food.

15 December 2022 in Supportive Care in Cancer
Verified
Journal Article
Closed access
PDF file
SMSoheila Manifar
Soheila Manifar
MKMaryam Koopaie
Maryam Koopaie
ZJZahra Mofazal Jahromi
Zahra Mofazal Jahromi
SKSajad Kolahdooz
Sajad Kolahdooz

4 October 2024 in BMC Oral Health
Verified
Journal Article
Open access
PDF file
MKMaryam Koopaie
Maryam Koopaie
PAParisa Akhbari
Parisa Akhbari
MFMahnaz Fatahzadeh
Mahnaz Fatahzadeh
SKSajad Kolahdooz
Sajad Kolahdooz
Oral lichen planus (OLP) is a chronic inflammatory condition that can impact patients’ quality of life. While its exact etiology remains unclear, it is associated with an increased risk of malignant transformation. Currently, the diagnosis of OLP relies on clinical examination and histopathological analysis, which can be invasive. Therefore, there is an urgent need for non-invasive and accurate diagnostic biomarkers. This systematic review and meta-analysis aims to investigate the potential of salivary microRNAs as promising candidates for OLP diagnosis. This meta-analysis seeks to identify specific microRNAs that are differentially expressed and could serve as reliable biomarkers for OLP diagnosis. Our strategy involved searching for pertinent keywords in multiple academic databases including Cochrane Library, Embase, LIVIVO, MEDLINE, Ovid, ProQuest, Scopus, Web of Science, Espacenet, and Google Scholar search engine. Upon identification, articles were screened and data extracted from the eligible studies. Split component synthesis method was utilized to assess specificity, sensitivity, likelihood and diagnostic odds ratios. The random-effects meta-analysis approach was used to combine study findings and develop pooled diagnostic performance metrics. Hierarchical summary receiver operating characteristic (ROC) plots were generated to determine area under the curve. Subgroup analyses concerning the type of saliva and control groups were also performed. Among the fourteen studies included in our systematic review, five were eligible for meta-analysis. Salivary microRNAs showed the pooled sensitivity of 0.80 (95% Confidence Interval (95% CI): 0.68–0.88), specificity of 0.89 (95% CI: 0.82–0.94), diagnostic odds ratio of 28.45 (95% CI: 10.40–77.80), and area under the curve (AUC) of 0.93 for OLP diagnosis. Unstimulated saliva had higher sensitivity and specificity than oral swirl samples as the biomarker medium for OLP diagnosis. Meta-analysis uncovered that miR-27a, miR-137, miR-1290, miR-27b, miR-4484, miR-142, and miR-1246 had the highest diagnostic odds ratio for OLP. Our systematic review and meta-analysis demonstrate that salivary microRNAs can serve as valuable biomarkers for the diagnosis of OLP. The findings highlight the exceptional accuracy of salivary microRNAs in differentiating OLP patients from healthy controls and assessing the risk of malignant transformation.

12 August 2022 in European Journal of Clinical Investigation
Verified
Journal Article
Open access
MKMaryam Koopaie
Maryam Koopaie
SKSajad Kolahdooz
Sajad Kolahdooz
MFMahnaz Fatahzadeh
Mahnaz Fatahzadeh
ZAZainab Abdulkareem Aleedawi
Zainab Abdulkareem Aleedawi
Background: Pancreatic cancer is considered one of the most deadly malignancies, primarily because of its diagnostic challenges. We performed a systematic review and diagnostic meta‐analysis to evaluate the diagnostic value of noncoding salivary RNAs in pancreatic cancer diagnosis.Methods: Our investigation involved pertinent studies published in PubMed, Scopus, Web of Science, LIVIVO, Ovid and also the Google Scholar search engine. Specificity and sensitivity were calculated, as were positive and negative likelihood ratios (PLR and NLR), and the diagnostic odds ratio (DOR). The summary receiver‐operating characteristics and area under the curve were plotted and assessed.Results: This meta‐analysis and systematic review involved and examined five studies that contained 145 study units with a total of 2731 subjects (1465 pancreatic cancer patients versus 1266 noncancer controls). The pooled specificity, sensitivity, NLR, PLR and DOR were 0.783 (95% CI: 0.759–0.805), 0.829 (95% CI: 0.809–0.848), 0.309 (95% CI: 0.279–0.343), 3.386 (95% CI: 2.956–3.879) and 18.403 (95% CI: 14.753–22.954), respectively, with the area under the curve (AUC) equal to 0.882. Subgroup analyses were conducted based on the saliva type (unstimulated and stimulated), mean age of patients, sample size, type of control, serum carbohydrate antigen 19–9 (CA19‐9) level and type of salivary noncoding RNA (microRNA (miRNA) and long noncoding RNA (lncRNA)).Conclusions: The results of our systematic review and meta‐analysis suggest that noncoding RNA biomarkers in the stimulated saliva could be a promising approach for accurate pancreatic cancer diagnosis in the early stages.